Articles with public access mandates - Matthias Mann - Parkinson's UKLearn more
NoteFor this mandate, articles should be available from specific locations.
OverallDFGEuropean CommissionNIHBMBFHelmholtzSNSFDFFHHMIMRCWellcomeEMBLCancer Research UKCZISwedish Research CouncilNHMRCHFSPFWFCIHRLeducq Foundation, USANSFDoDDNRFKnut and Alice Wallenberg FoundationANRNWOBHFNIHRGovernment of SpainMichael J Fox FoundationV Foundation, USAAHAVolkswagen FoundationINSERMBBSRCGovernment of ItalyGatesGenome CanadaTelethonParkinson's UKWorldwide Cancer Research, UKUK Research & InnovationCarlsberg Foundation DKNASAVANSERCNSFCDSFOTKASFIFCTA*StarAlzheimers's UKBlood Cancer UKNERCProstate Cancer UKZonMwRCNDoris Duke Charitable FoundationInnovation Fund DenmarkSCLDHFSwedish Environmental Protection AgencyBusiness FinlandAIRC Foundation for Cancer Research in ItalyDamon Runyon Cancer Research FoundationNational Research Foundation, SingaporeAXA Research Fund, FranceCPRIT
Available based on mandate: 2
Development of phospho-specific Rab protein antibodies to monitor in vivo activity of the LRRK2 Parkinson's disease kinase
P Lis, S Burel, M Steger, M Mann, F Brown, F Diez, F Tonelli, JL Holton, ...
Biochemical Journal 475 (1), 1-22, 2018
Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases
M Steger, F Tonelli, G Ito, P Davies, M Trost, M Vetter, S Wachter, ...
elife 5, e12813, 2016
Publication and funding information is determined automatically by a computer program